Extrapolate Extrapolate
  • 888-328-2189
  • ABOUT US
  • CONTACT US
  • SIGN IN
  • INDUSTRIES
  • BLOGS
  • Home
  • Healthcare, Medical Devices & Biotechnology
  • Cell and gene therapy drug delivery devices market report

Global Cell and Gene Therapy Drug Delivery Devices Market Insights, Forecast to 2028

  • Description
  • Table Of Content
  • Sample Request

Table Of Contents

1 Report Business Overview

1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sterile Insulin Syringe
1.2.3 Pre-Filled Syringe
1.2.4 Infusion Bags
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Luxturna
1.3.3 Kymriah
1.3.4 Provenge
1.3.5 Zolgensma
1.3.6 Yescarta
1.3.7 Strimvelis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region
2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics
2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends
2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue
3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2021
3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type
4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application
5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type
7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application
7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen, Inc.
11.1.1 Amgen, Inc. Company Details
11.1.2 Amgen, Inc. Business Overview
11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.1.5 Amgen, Inc. Recent Developments
11.2 Bausch and Lomb Incorporated
11.2.1 Bausch and Lomb Incorporated Company Details
11.2.2 Bausch and Lomb Incorporated Business Overview
11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.2.5 Bausch and Lomb Incorporated Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Developments
11.4 Bluebird bio, Inc.
11.4.1 Bluebird bio, Inc. Company Details
11.4.2 Bluebird bio, Inc. Business Overview
11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.4.5 Bluebird bio, Inc. Recent Developments
11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Dendreon Pharmaceuticals LLC. Company Details
11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.6.5 Dendreon Pharmaceuticals LLC. Recent Developments
11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
11.8 Human Stem Cell Institute
11.8.1 Human Stem Cell Institute Company Details
11.8.2 Human Stem Cell Institute Business Overview
11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.8.5 Human Stem Cell Institute Recent Developments
11.9 Kite Pharma, Inc.
11.9.1 Kite Pharma, Inc. Company Details
11.9.2 Kite Pharma, Inc. Business Overview
11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.9.5 Kite Pharma, Inc. Recent Developments
11.10 Kolon Tissue Gene, inc.
11.10.1 Kolon Tissue Gene, inc. Company Details
11.10.2 Kolon Tissue Gene, inc. Business Overview
11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.10.5 Kolon Tissue Gene, inc. Recent Developments
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.11.5 Novartis AG Recent Developments
11.12 Orchard Therapeutics plc.
11.12.1 Orchard Therapeutics plc. Company Details
11.12.2 Orchard Therapeutics plc. Business Overview
11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.12.5 Orchard Therapeutics plc. Recent Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.13.5 Pfizer, Inc. Recent Developments
11.14 Renova Therapeutics
11.14.1 Renova Therapeutics Company Details
11.14.2 Renova Therapeutics Business Overview
11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.14.5 Renova Therapeutics Recent Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Details
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.15.5 Spark Therapeutics, Inc. Recent Developments
11.16 uniQure N.V.
11.16.1 uniQure N.V. Company Details
11.16.2 uniQure N.V. Business Overview
11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.16.5 uniQure N.V. Recent Developments
11.17 Vericel Corporation
11.17.1 Vericel Corporation Company Details
11.17.2 Vericel Corporation Business Overview
11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.17.5 Vericel Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

ARE YOU SEEKING COMPREHENSIVE INSIGHT ON VARIOUS MARKETS?
CONTACT OUR EXPERTS TODAY
Speak to an Expert

Global Cell and Gene Therapy Drug

  • November-2022
  • 111
  • Global
  • healthcare-medical-devices-biotechnology
3499

SELECT AN OPTION

  • 1 User Access
  • PDF Report View
  • Non-Printable
  • 32 Man-hours Analyst Support
  • Post-Sale Support 48 Hours
  • Access upto 5 users
  • PDF Report View
  • Print Available
  • Access to Data Sheet
  • Up to 10% Customization
  • 40 Man-hours Analyst Support
  • Post-Sale Support 72 Hours
  • Annual Update
  • Unlimited User Access
  • Downloadable PDF Report. Data Sheet, Power Point Presentation
  • Print Available
  • Up to 20% Customization
  • 72 Man-hours Analyst Support
  • Post-Sale Support 120 Hours
  • Bi-Annual Update

ENQUIRE NOW REQUEST SAMPLE
Dale Byrne

HAVE A QUESTION?
Samuel will help you find what you are looking for.

Call: 888-328-2189




Related Research

2022-2030 Global and Regional B-Cell Non-Hodgkin`s Lymphoma (NHL) Treatment Industry Production, Sa

February-2021

2022-2030 Global and Regional Organ Transplant Diagnostics Industry Production, Sales and Consumpti

February-2021

2022-2030 Global and Regional Prostacyclin Drug Industry Production, Sales and Consumption Status a

February-2021

2022-2030 Global and Regional Spinal and Bulbar Muscular Atrophy Treatment Industry Production, Sal

February-2021

2% Chlorhexidine Gluconate (CHG) Cloths-Global Market Status & Trend Report 2022-2030 Top 20 Countri

April-2021

2% Chlorhexidine Gluconate (CHG) Cloths-Global Market Status and Trend Report 2022-2030

April-2021

2021-2027 Global and RegioAnal Nasal Gels Industry Production, Sales and Consumption Status and Pros

February-2021

2021-2027 Global and Regional 2019-nCoV Detection Server Industry Production, Sales and Consumption

February-2021

2021-2027 Global and Regional ? Collagen Quantitative Determination Kit Industry Production, Sales a

February-2021

2021-2027 Global and Regional Anti-TNF Monoclonal Antibody Industry Production, Sales and Consumptio

February-2021
Sample Request
Global Cell and Gene Therapy Drug Delivery Devices Market Insights, Forecast to 2028
Publisher: QY Research   |   Date: 2022-11-28  |   No. Of Pages: 111
Send Your Query
Global Cell and Gene Therapy Drug Delivery Devices Market Insights, Forecast to 2028
Publisher: QY Research   |   Date: 2022-11-28  |   No. Of Pages: 111
Extrapolate

Extrapolate has a refined network of top publishers across the globe covering markets and micro markets who bring in the power of decision making. Our network of publishers is ranked based on the quality of reports produced along with customer feedback Indexing.

 talk@extrapolate.com

888-328-2189


Connect With Us

twitter logo

Industry

Quick Links

  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Disclaimer
  • Refund Policy
  • Sitemap



Payment Gateway
Sign up for newsletter and updates


Powered By

Kings Research
© 2025 Kingsresearch. All Rights Reserved.